Article Versions Notes

Sistani G, Sutherland DEK, Mujoomdar A, Wiseman DP, Khatami A, Tsvetkova E, Reid RH, Laidley DT. Efficacy of ¹⁷⁷Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study. Current Oncology. 2021; 28(1):115-127. https://doi.org/10.3390/curroncol28010015

Sistani, Golmehr, Duncan E. K. Sutherland, Amol Mujoomdar, Daniele P. Wiseman, Alireza Khatami, Elena Tsvetkova, Robert H. Reid, and David T. Laidley. 2021. "Efficacy of ¹⁷⁷Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study" Current Oncology 28, no. 1: 115-127. https://doi.org/10.3390/curroncol28010015

Sistani, G., Sutherland, D. E. K., Mujoomdar, A., Wiseman, D. P., Khatami, A., Tsvetkova, E., Reid, R. H., & Laidley, D. T. (2021). Efficacy of ¹⁷⁷Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study. Current Oncology, 28(1), 115-127. https://doi.org/10.3390/curroncol28010015